1)endostatin血管内皮抑制素
1.Pharmacokinetics of recombinant human endostatin in healthy volunteers and patients with advanced solid tumors;重组人血管内皮抑制素的人体药动学
2.Progress of a novel antitumour drug-Endostatin;抗肿瘤新药血管内皮抑制素的研究进展
3.Anti-Tumor Effect of Recombinant Human Endostatin on the Growth of Mouse Lewis Lung Carcinoma;重组人血管内皮抑制素对小鼠Lewis肺癌肿瘤抑制作用
英文短句/例句
1.Clinical application of recombinant human endostatin重组人血管内皮抑制素临床应用进展
2.Biological Properties and Recombinant Human Vascular Endostatin Therapy of Hemangioma: Study on Hemangioma Endothelial Cells in Vitro Culture血管瘤内皮细胞的生物特性和重组人血管内皮抑制素对血管瘤内皮细胞作用的实验研究
3.Outlook of endostatin inhibit ocular neovascularization血管内皮抑素对眼内新生血管抑制的展望
4.Studies on Experimental Choroidal Neovascularization Inhibited by Endostatin Genetherapy;内皮抑素抑制脉络膜新生血管的实验研究
5.Experimental Study on the Inhibition of Corneal Neovascularization with Recombinant Human Endostatin;重组人内皮抑素抑制角膜新生血管的实验研究
6.NUMERICAL SIMULATION OF INHIBITORY EFFECTS OF ENDOSTATIN ON TUMOR ANGIOGENESIS内皮抑素抑制肿瘤血管生成的数值模拟
7.Anti-inflammatory Effect of ABL in Experimental De-endothelium and Hyperlipidemia Rats;旋覆花素抑制血管内皮剥脱和高脂血症所致的血管炎性反应
8.A Study on the Expression, Mechanism and Intervention of Endostatin and Angiostain in Myocardial Infarction Rats;心肌梗死大鼠内皮抑素、血管抑素的表达及其机制和干预研究
9.An Experimental Study of Anti-Angiogenesis with Low Mocular Weight Heparin Endostatin;低分子肝素化内皮抑素抑制兔角膜新生血管的实验研究
10.Mechanism and Effects of Glucose on Endostatin Expression in Vascular Endothelial Cells;葡萄糖对血管内皮细胞内皮抑素表达的影响及其调控机制的研究
11.Inhibitory Effect and Mechanism of Endostatin on the Angiogenesis of Xenografted Namalwa Lymphoma in Nude Mice内皮抑素抑制Namalwa淋巴瘤裸鼠移植瘤肿瘤血管生成的作用及其机制
12.Anti-angiogenesis effects of human angiostatin and endostatin persistently secreted by in vitro genetically engineered cells体外培养下可持续分泌人血管抑素和内皮抑素基因工程细胞对血管生成的抑制效应
13.Study of Endostatin and Its Mimic-peptides in Inhibiting Angiogenesis;内皮抑素及其噬菌体模拟肽抑制新血管形成研究
14.Endostatin Gene Transfer for Inhibition of Retinal Angiogenesis in Mouse;内皮抑素基因转移抑制视网膜新生血管的实验研究
15.An Experimental Study of Anti-Angiogenesis with Polyethylene Glycol Modified Endostatin;聚乙二醇化内皮抑素抑制小鼠视网膜新生血管的实验研究
16.Significance of Angiostatin (Endostatin) in Hypertrophic Scars of Rabbit Ear;血管生长抑制因子(内皮抑素)对兔耳增生性瘢痕的作用及意义
17.An Experimental Study of Endostatin and Modified Endostatin and Their Angiogenesis Effect on Mouse Choroid;内皮抑素及其修饰物对脉络膜新生血管抑制作用的实验研究
18.The Experimental Study of Recombinant Human Endostatin Inhibiting on Corneal Neovascularization of Rats;重组人内皮抑素对大鼠角膜新生血管抑制作用的实验研究
相关短句/例句
recombinant human Endostatin重组人血管内皮抑制素
1.Clinical application of recombinant human endostatin重组人血管内皮抑制素临床应用进展
2.The fermentation process of recombinant human Endostatin expression in Escherichia coli BL21 (DE3) was studied.优化了重组人血管内皮抑制素的E。
3.In order to instruct reasonable application of the recombinant Human Endostatin ,the development in clinical research of Endostar for malignant tumor were reviewed in this paper,including clinical results,drug adverse reactions and qulity of life.介绍重组人血管内皮抑制素(恩度)治疗恶性肿瘤的临床研究情况,包括临床疗效、不良反应和生活质量方面的研究进展,为临床合理应用和评价新药提供参考。
3)vasostatin120 180血管内皮抑制素120-180
4)Homemade human rh-endostatin重组人血管内皮抑制素
1.Observation of early curative effect of homemade human rh-endostatin injection in combination with chemotherapy for advanced non-small cell lung cancer;重组人血管内皮抑制素联合化疗治疗晚期非小细胞肺癌近期疗效观察
5)endostatin-vascular endothelial growth inhibitor内皮抑素-血管内皮细胞抑制因子
1.Inhibitory effects of endostatin-vascular endothelial growth inhibitor recombinant adenoviruses on neovascularization;内皮抑素-血管内皮细胞抑制因子重组腺病毒对新生血管的抑制效应
6)Endostatin血管内皮抑素
1.Correlation of Pretreatment Serum Level of Endostatin to Posttreatment Distant Metastasis in Patients with Advanced Nasopharyngeal Carcinoma;治疗前外周血血管内皮抑素浓度与局部晚期鼻咽癌治疗后远处转移的关系
2.Advances in Endostatin Therapy for Non-small Cell Lung Cancer;血管内皮抑素在非小细胞肺癌治疗中的研究进展
3.Research on the Antitumor Effect of Endostatin Associate with Chemotherapy and Discussion of Its Mechanisms;血管内皮抑素联合化疗抗肿瘤疗效观察及机制讨论
延伸阅读
舒血管素 ,血管舒缓素药物名称:血管舒缓素英文名:Kallidinogenase别名: 保妥丁;激太积放酶;舒血管素 ,血管舒缓素外文名:Kallidinogenase适应症: 用于脑动脉硬化症、闭塞性动脉内膜炎、闭塞性血管炎、四肢慢性溃疡、肢端动脉痉挛症、手足发绀、老年性四肢冷感、中央视网膜炎、眼底出血等。也用于冠心病、心绞痛、视网膜血流障碍。 用量用法: 1.注射:临用时溶解(每1.5ml10单位)后进行肌注或皮注1次量10~20单位,每日1~2次。轻症每日10单位,以3周为1疗程。眼科亦可作眼结膜下注射,每次5单位。 2.口服:每次1片(含10单位),空腹时服。 注意事项: 1.凡肿瘤、颅内压增高、心力衰竭病人忌用。 2.有些病人应用后可出现疼痛反应。 3.本品对热、酸、碱、氧化剂均不稳定。 规格: 注射用血管舒缓素:每支10单位。片剂:每片10单位。 类别:周围血管扩张药
